The missing link in the amyloid cascade of Alzheimer's disease-Metal ions

Neurochemistry International

Volumn 62, Issue 4, 2013, Pages 367-378

  Tiiman, Ann ^a   Palumaa, Peep ^a   Tõugu, Vello ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

Alzheimer's disease; Amyloid beta; Metal ions

Indexed keywords

ALPHA SECRETASE; ALUMINUM; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; BETA SECRETASE; COPPER; GAMMA SECRETASE; IRON; METAL ION; PRESENILIN; ZINC;

ALZHEIMER DISEASE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN LEVEL; GENE MUTATION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; THROMBOCYTE AGGREGATION;

EID: 84874587315     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.01.023     Document Type: Short Survey

References (194)

1. A. Abedini, and D.P. Raleigh A role for helical intermediates in amyloid formation by natively unfolded polypeptides? Phys. Biol. 6 2009 015005
2. P.A. Adlard, R.A. Cherny, D.I. Finkelstein, E. Gautier, E. Robb, M. Cortes, I. Volitakis, X. Liu, J.P. Smith, K. Perez, K. Laughton, Q.X. Li, S.A. Charman, J.A. Nicolazzo, S. Wilkins, K. Deleva, T. Lynch, G. Kok, C.W. Ritchie, R.E. Tanzi, R. Cappai, C.L. Masters, K.J. Barnham, and A.I. Bush Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta Neuron 59 2008 43 55
3. M. Ahmed, J. Davis, D. Aucoin, T. Sato, S. Ahuja, S. Aimoto, J.I. Elliott, W.E. Van Nostrand, and S.O. Smith Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils Nat. Struct. Biol. 17 2010 U556 U561
4. A.T. Alexandrescu Amyloid accomplices and enforcers Protein Sci. 14 2005 1 12
5. F.E. Ali, F. Separovic, C.J. Barrow, S.G. Yao, and K.J. Barnham Copper and zinc mediated oligomerisation of A beta peptides Int. J. Pept. Res. Ther. 12 2006 153 164
6. 2+ from brain tissue during activity Nature 308 1984 734 736
7. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, D.P. Fairlie, R.E. Tanzi, and A.I. Bush Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42 J. Neurochem. 75 2000 1219 1233
8. C. Balducci, M. Beeg, M. Stravalaci, A. Bastone, A. Sclip, E. Biasini, L. Tapella, L. Colombo, C. Manzoni, T. Borsello, R. Chiesa, M. Gobbi, M. Salmona, and G. Forloni Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein Proc. Natl. Acad. Sci. USA 107 2010 2295 2300
9. E.J. Baran Chelation therapies: a chemical and biochemical perspective Curr. Med. Chem. 17 2010 3658 3672
10. R.T. Bartus, R.L. Dean, B. Beer, and A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 417
11. T.A. Bayer, S. Schafer, A. Simons, A. Kemmling, T. Kamer, R. Tepest, A. Eckert, K. Schussel, O. Eikenberg, C. Sturchler-Pierrat, D. Abramowski, M. Staufenbiel, and G. Multhaup Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid A beta production in APP23 transgenic mice Proc. Natl. Acad. Sci. USA 100 2003 14187 14192
12. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat. Rev. Neurol. 6 2010 131 144
13. K. Broersen, F. Rousseau, and J. Schymkowitz The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res. Ther. 2 2010 12
14. K.L. Brugge, S.L. Nichols, D.P. Salmon, L.R. Hill, D.C. Delis, L. Aaron, and D.A. Trauner Cognitive impairment in adults with Down's syndrome: similarities to early cognitive changes in Alzheimer's disease Neurology 44 1994 232 238
15. A.I. Bush Metals and neuroscience Curr. Opin. Chem. Biol. 4 2000 184 191
16. A.I. Bush The metallobiology of Alzheimer's disease Trends Neurosci. 26 2003 207 214
17. A.I. Bush, W.H. Pettingell, G. Multhaup, M. d Paradis, J.P. Vonsattel, J.F. Gusella, K. Beyreuther, C.L. Masters, and R.E. Tanzi Rapid induction of Alzheimer A beta amyloid formation by zinc Science 265 1994 1464 1467
18. A.I. Bush, and R.E. Tanzi Therapeutics for Alzheimer's disease based on the metal hypothesis Neurotherapeutics 5 2008 421 432
19. R.J. Castellani, R.K. Rolston, and M.A. Smith Alzheimer disease Dis Mon 56 2010 484 546
20. J.M. Castellano, J. Kim, F.R. Stewart, H. Jiang, R.B. DeMattos, B.W. Patterson, A.M. Fagan, J.C. Morris, K.G. Mawuenyega, C. Cruchaga, A.M. Goate, K.R. Bales, S.M. Paul, R.J. Bateman, and D.M. Holtzman Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance Sci. Transl. Med. 3 2011 89ra57
21. G. Chen, K.S. Chen, J. Knox, J. Inglis, A. Bernard, S.J. Martin, A. Justice, L. McConlogue, D. Games, S.B. Freedman, and R.G. Morris A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease Nature 408 2000 975 979
22. 3+ on amyloid-beta stability, oligomerization, and aggregation J. Biol. Chem. 286 2011 9646 9656
23. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, C.A. McLean, K.J. Barnham, I. Volitakis, F.W. Fraser, Y. Kim, X. Huang, L.E. Goldstein, R.D. Moir, J.T. Lim, K. Beyreuther, H. Zheng, R.E. Tanzi, C.L. Masters, and A.I. Bush Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 2001 665 676
24. R.A. Cherny, J.T. Legg, C.A. McLean, D.P. Fairlie, X. Huang, C.S. Atwood, K. Beyreuther, R.E. Tanzi, C.L. Masters, and A.I. Bush Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion J. Biol. Chem. 274 1999 23223 23228
25. R.S. Chung, C. Howells, E.D. Eaton, L. Shabala, K. Zovo, P. Palumaa, R. Sillard, A. Woodhouse, W.R. Bennett, S. Ray, J.C. Vickers, and A.K. West The native copper- and zinc-binding protein metallothionein blocks copper-mediated A beta aggregation and toxicity in rat cortical neurons PLoS One 5 2010 e12030
26. P. Cizas, R. Budvytyte, R. Morkuniene, R. Moldovan, M. Broccio, M. Losche, G. Niaura, G. Valincius, and V. Borutaite Size-dependent neurotoxicity of beta-amyloid oligomers Arch. Biochem. Biophys. 496 2010 84 92
27. M. Citron, C. Vigopelfrey, D.B. Teplow, C. Miller, D. Schenk, J. Johnston, B. Winblad, N. Venizelos, L. Lannfelt, and D.J. Selkoe Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer-disease mutation Proc. Natl. Acad. Sci. USA 91 1994 11993 11997
28. E.D. Ciuculescu, Y. Mekmouche, and P. Faller Metal-binding properties of the peptide APP(170-188): a model of the Zn-II-binding site of amyloid precursor protein (APP) Chem. Eur. J. 11 2005 903 909
29. A. Clements, D. Allsop, D.M. Walsh, and C.H. Williams Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease J. Neurochem. 66 1996 740 747
30. E.H. Corder, A.M. Saunders, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell, G.W. Small, A.D. Roses, J.L. Haines, and M.A. Pericak-Vance Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 261 1993 921 923
31. C. Corona, F. Masciopinto, E. Silvestri, A. Del Viscovo, R. Lattanzio, R. La Sorda, D. Ciavardelli, F. Goglia, M. Piantelli, L.M.T. Canzoniero, and S.L. Sensi Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction Cell Death Dis. 1 2010 e91
32. P.J. Crouch, D.J. Tew, T. Du, D.N. Nguyen, A. Caragounis, G. Filiz, R.E. Blake, I.A. Trounce, C.P. Soon, K. Laughton, K.A. Perez, Q.X. Li, R.A. Cherny, C.L. Masters, K.J. Barnham, and A.R. White Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation J. Neurochem. 108 2009 1198 1207
33. C. Cruchaga, S. Chakraverty, K. Mayo, F.L.M. Vallania, R.D. Mitra, K. Faber, J. Williamson, T. Bird, R. Diaz-Arrastia, T.M. Foroud, B.F. Boeve, N.R. Graff-Radford, P.S. Jean, M. Lawson, M.G. Ehm, R. Mayeux, A.M. Goate, and N.-L.N.F.S. Consor Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families PLoS One 7 2012 e31039
34. B.J. Cummings, and C.W. Cotman Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity Lancet 346 1995 1524 1528
35. J.L. Cummings, H.V. Vinters, G.M. Cole, and Z.S. Khachaturian Alzheimer's disease-etiologies, pathophysiology, cognitive reserve, and treatment opportunities Neurology 51 1998 S2 S17
36. K.N. Dahlgren, A.M. Manelli, W.B. Stine, L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
37. J. Danielsson, R. Pierattelli, L. Banci, and A. Graslund High-resolution NMR studies of the zinc-binding site of the Alzheimer's amyloid beta-peptide FEBS J. 274 2007 46 59
38. G.V. De Ferrari, and N.C. Inestrosa Wnt signaling function in Alzheimer's disease Brain Res. Rev. 33 2000 1 12
39. A.S. DeToma, S. Salamekh, A. Ramamoorthy, and M.H. Lim Misfolded proteins in Alzheimer's disease and type II diabetes Chem. Soc. Rev. 41 2012 608 621
40. J. Dong, C.S. Atwood, V.E. Anderson, S.L. Siedlak, M.A. Smith, G. Perry, and P.R. Carey Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence Biochemistry 42 2003 2768 2773
41. J.A. Duce, and A.I. Bush Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics Prog. Neurobiol. 92 2010 1 18
42. C. Duyckaerts, M.C. Potier, and B. Delatour Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathol. 115 2008 5 38
43. C.B. Eckman, N.D. Mehta, R. Crook, J. Perez-tur, G. Prihar, E. Pfeiffer, N. Graff-Radford, P. Hinder, D. Yager, B. Zenk, L.M. Refolo, C.M. Prada, S.G. Younkin, M. Hutton, and J. Hardy A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43) Hum. Mol. Genet. 6 1997 2087 2089
44. G. Eskici, and P.H. Axelsen Copper and oxidative stress in the pathogenesis of Alzheimer's disease Biochemistry 51 2012 6289 6311
45. W.P. Esler, E.R. Stimson, J.M. Jennings, J.R. Ghilardi, P.W. Mantyh, and J.E. Maggio Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro J. Neurochem. 66 1996 723 732
46. C. Exley The aluminium-amyloid cascade hypothesis and Alzheimer's disease Subcell. Biochem. 38 2005 225 234
47. C. Exley The coordination chemistry of aluminium in neurodegenerative disease Coord. Chem. Rev. 256 2012 2142 2146
48. P. Faller, and C. Hureau Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide Dalton Trans. 2009 1080 1094
49. C.J. Frederickson, and A.I. Bush Synaptically released zinc: physiological functions and pathological effects Biometals 14 2001 353 366
50. C.J. Frederickson, J.Y. Koh, and A.I. Bush The neurobiology of zinc in health and disease Nat. Rev. Neurosci. 6 2005 449 462
51. D.B. Freir, R. Fedriani, D. Scully, I.M. Smith, D.J. Selkoe, D.M. Walsh, and C.M. Regan Abeta oligomers inhibit synapse remodelling necessary for memory consolidation Neurobiol. Aging 32 2011 2211 2218
52. H. Fukuda, T. Shimizu, M. Nakajima, H. Mori, and T. Shirasawa Synthesis, aggregation, and neurotoxicity of the Alzheimer's A beta 1-42 amyloid peptide and its isoaspartyl isomers Bioorg. Med. Chem. Lett. 9 1999 953 956
53. E. Gaggelli, H. Kozlowski, D. Valensin, and G. Valensin Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis) Chem. Rev. 106 2006 1995 2044
54. D. Galimberti, C. Fenoglio, and E. Scarpini Inflammation in neurodegenerative disorders: friend or foe? Curr. Aging Sci. 1 2008 30 41
55. D. Galimberti, and E. Scarpini Progress in Alzheimer's disease J. Neurol. 259 2012 201 211
56. W. Garzon-Rodriguez, A.K. Yatsimirsky, and C.G. Glabe Binding of Zn(II), Cu(II), and Fe(II) ions to Alzheimer's A beta peptide studied by fluorescence Bioorg. Med. Chem. Lett. 9 1999 2243 2248
57. M. Gatz, C.A. Reynolds, L. Fratiglioni, B. Johansson, J.A. Mortimer, S. Berg, A. Fiske, and N.L. Pedersen Role of genes and environments for explaining Alzheimer disease Arch. Gen. Psychiatry 63 2006 168 174
58. M.L. Giuffrida, F. Caraci, B. Pignataro, S. Cataldo, P. De Bona, V. Bruno, G. Molinaro, G. Pappalardo, A. Messina, A. Palmigiano, D. Garozzo, F. Nicoletti, E. Rizzarelli, and A. Copani Beta-amyloid monomers are neuroprotective J. Neurosci. 29 2009 10582 10587
59. T.E. Golde Alzheimer disease therapy: can the amyloid cascade be halted? J. Clin. Invest. 111 2003 11 18
60. C. Goldsbury, U. Baxa, M.N. Simon, A.C. Steven, A. Engel, J.S. Wall, U. Aebi, and S.A. Muller Amyloid structure and assembly: insights from scanning transmission electron microscopy J. Struct. Biol. 173 2011 1 13
61. M.N. Gordon, D.L. King, D.M. Diamond, P.T. Jantzen, K.V. Boyett, C.E. Hope, J.M. Hatcher, G. DiCarlo, W.P. Gottschall, D. Morgan, and G.W. Arendash Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice Neurobiol. Aging 22 2001 377 385
62. I. Grundkeiqbal, J. Fleming, Y.C. Tung, H. Lassmann, K. Iqbal, and J.G. Joshi Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia Acta Neuropathol. 81 1990 105 110
63. C. Ha, J. Ryu, and C.B. Park Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template Biochemistry 46 2007 6118 6125
64. C. Haass Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation EMBO J. 23 2004 483 488
65. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
66. B. Halliwell, and J.M.C. Gutteridge Oxygen-toxicity, oxygen radicals, transition-metals and disease Biochem. J. 219 1984 1 14
67. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
68. J.A. Hardy, and G.A. Higgins Alzheimers-disease-the amyloid cascade hypothesis Science 256 1992 184 185
69. J.D. Harper, and P.T. Lansbury Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
70. R.S. Harrison, P.C. Sharpe, Y. Singh, and D.P. Fairlie Amyloid peptides and proteins in review Rev. Physiol. Biochem. Pharmacol. 159 2007 1 77
71. D.E. Hartter, and A. Barnea Evidence for release of copper in the brain: depolarization-induced release of newly taken-up 67copper Synapse 2 1988 412 415
72. L.Q. Hatcher, L. Hong, W.D. Bush, T. Carducci, and J.D. Simon Quantification of the binding constant of copper(II) to the amyloid-beta peptide J. Phys. Chem. B 112 2008 8160 8164
73. H.C. Hendrie Epidemiology of dementia and Alzheimer's disease Am. J. Geriatr. Psychiatry 6 1998 S3 18
74. H.Q. Hua, L. Munter, A. Harmeier, O. Georgiev, G. Multhaup, and W. Schaffner Toxicity of Alzheimer's disease-associated A beta peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability Biol. Chem. 392 2011 919 926
75. X. Huang, M.P. Cuajungco, C.S. Atwood, M.A. Hartshorn, J.D. Tyndall, G.R. Hanson, K.C. Stokes, M. Leopold, G. Multhaup, L.E. Goldstein, R.C. Scarpa, A.J. Saunders, J. Lim, R.D. Moir, C. Glabe, E.F. Bowden, C.L. Masters, D.P. Fairlie, R.E. Tanzi, and A.I. Bush Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction J. Biol. Chem. 274 1999 37111 37116
76. X. Huang, R.D. Moir, R.E. Tanzi, A.I. Bush, and J.T. Rogers Redox-active metals, oxidative stress, and Alzheimer's disease pathology Ann. N Y Acad. Sci. 1012 2004 153 163
77. Y.H. Hung, A.I. Bush, and R.A. Cherny Copper in the brain and Alzheimer's disease J. Biol. Inorg. Chem. 15 2010 61 76
78. C. Hureau Coordination of redox active metal ions to the amyloid precursor protein and to amyloid-beta peptides involved in Alzheimer disease. Part 1: an overview Coord. Chem. Rev. 256 2012 2164 2174
79. R. Jakob-Roetne, and H. Jacobsen Alzheimer's disease: from pathology to therapeutic approaches Angew. Chem. Int. Ed. Engl. 48 2009 3030 3059
80. 2 derived from NADPH oxidase: a cell culture study J. Neuroinflamm. 3 2006 24
81. D. Jiang, X. Li, L. Liu, G.B. Yagnik, and F. Zhou Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates J. Phys. Chem. B 114 2010 4896 4903
82. D. Jiang, L. Men, J. Wang, Y. Zhang, S. Chickenyen, Y. Wang, and F. Zhou Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathalogical relevance Biochemistry 46 2007 9270 9282
83. D. Jiang, L. Zhang, G.P.G. Grant, C.G. Dudzik, S. Chen, S. Patel, Y. Hao, G.L. Millhauser, and F. Zhou Elevated copper binding strength of amyloid-β aggregates enables their copper sequestration from albumin: a pathway to accumulation of copper in senile plaques 2012 Biochemistry
84. M.A. Johnson, J.G. Fischer, and S.E. Kays Is copper an antioxidant nutrient Crit. Rev. Food Sci. Nutr. 32 1992 1 31
85. J.A. Johnston, R.F. Cowburn, S. Norgren, B. Wiehager, N. Venizelos, B. Winblad, C. Vigopelfrey, D. Schenk, L. Lannfelt, and C. Oneill Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell-lines from family members with the Swedish Alzheimers-disease APP670/671 mutation FEBS Lett. 354 1994 274 278
86. T. Jonsson, J.K. Atwal, S. Steinberg, J. Snaedal, P.V. Jonsson, S. Bjornsson, H. Stefansson, P. Sulem, D. Gudbjartsson, J. Maloney, K. Hoyte, A. Gustafson, Y. Liu, Y. Lu, T. Bhangale, R.R. Graham, J. Huttenlocher, G. Bjornsdottir, O.A. Andreassen, E.G. Jonsson, A. Palotie, T.W. Behrens, O.T. Magnusson, A. Kong, U. Thorsteinsdottir, R.J. Watts, and K. Stefansson A mutation in APP protects against Alzheimer/'s disease and age-related cognitive decline Nature 488 2012 96 99
87. J. Kardos, I. Kovacs, F. Hajos, M. Kalman, and M. Simonyi Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitability Neurosci. Lett. 103 1989 139 144
88. 2+ binding site in amyloid-beta Biochemistry 44 2005 5478 5487
89. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discov. 10 2011 698 U1600
90. J. Kim, J.M. Basak, and D.M. Holtzman The role of apolipoprotein E in Alzheimer's disease Neuron 63 2009 287 303
91. G.M. Klug, D. Losic, S.S. Subasinghe, M.I. Aguilar, L.L. Martin, and D.H. Small Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH Eur. J. Biochem. 270 2003 4282 4293
92. T.P.J. Knowles, C.A. Waudby, G.L. Devlin, S.I.A. Cohen, A. Aguzzi, M. Vendruscolo, E.M. Terentjev, M.E. Welland, and C.M. Dobson An analytical solution to the kinetics of breakable filament assembly Science 326 2009 1533 1537
93. A. Kurz, K. Altland, N. Lautenschlager, R. Zimmer, R. Busch, I. Gerundt, H. Lauter, and U. Muller Apolipoprotein E type 4 allele and Alzheimer's disease: effect on age at onset and relative risk in different age groups J. Neurol. 243 1996 452 456
94. J.B.J. Kwok, G.M. Halliday, W.S. Brooks, G. Dolios, H. Laudon, O. Murayama, M. Hallupp, R.F. Badenhop, J. Vickers, R. Wang, J. Naslund, A. Takashima, S.E. Gandy, and P.R. Schofield Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy J. Biol. Chem. 278 2003 6748 6754
95. L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames, J. Harrison, C.L. Masters, S. Targum, A.I. Bush, R. Murdoch, J. Wilson, and C.W. Ritchie Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Lancet Neurol. 7 2008 779 786
96. J.Y. Lee, T.B. Cole, R.D. Palmiter, S.W. Suh, and J.Y. Koh Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice Proc. Natl. Acad. Sci. USA 99 2002 7705 7710
97. Y.J. Lee, S.B. Han, S.Y. Nam, K.W. Oh, and J.T. Hong Inflammation and Alzheimer's disease Arch. Pharmacal Res. 33 2010 1539 1556
98. S. Lesne, M.T. Koh, L. Kotilinek, R. Kayed, C.G. Glabe, A. Yang, M. Gallagher, and K.H. Ashe A specific amyloid-beta protein assembly in the brain impairs memory Nature 440 2006 352 357
99. D.H. Linkous, P.A. Adlard, P.B. Wanschura, K.M. Conko, and J.M. Flinn The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice J. Alzheimers Dis. 18 2009 565 579
100. A. Lorenzo, and B.A. Yankner Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red Proc. Natl. Acad. Sci. USA 91 1994 12243 12247
101. M.A. Lovell, and W.R. Markesbery Oxidative damaore in mild cognitive impairment and early Alzhelimer's disease J. Neurosci. Res. 85 2007 3036 3040
102. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell, and W.R. Markesbery Copper, iron and zinc in Alzheimer's disease senile plaques J. Neurol. Sci. 158 1998 47 52
103. L.F. Lue, Y.M. Kuo, A.E. Roher, L. Brachova, Y. Shen, L. Sue, T. Beach, J.H. Kurth, R.E. Rydel, and J. Rogers Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease Am. J. Pathol. 155 1999 853 862
104. A.M. Mancino, S.S. Hindo, A. Kochi, and M.H. Lim Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited Inorg. Chem. 48 2009 9596 9598
105. A.M. Manelli, L.C. Bulfinch, P.M. Sullivan, and M.J. LaDu Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation Neurobiol. Aging 28 2007 1139 1147
106. C. Manzoni, L. Colombo, P. Bigini, V. Diana, A. Cagnotto, M. Messa, M. Lupi, V. Bonetto, M. Pignataro, C. Airoldi, E. Sironi, A. Williams, and M. Salmona The molecular assembly of amyloid A beta controls its neurotoxicity and binding to cellular proteins PLoS One 6 2011 e24909
107. I.C. Martins, I. Kuperstein, H. Wilkinson, E. Maes, M. Vanbrabant, W. Jonckheere, P. Van Gelder, D. Hartmann, R. D'Hooge, B. De Strooper, J. Schymkowitz, and F. Rousseau Lipids revert inert A beta amyloid fibrils to neurotoxic protofibrils that affect learning in mice EMBO J. 27 2008 224 233
108. C.L. Masters, and D.J. Selkoe Biochemistry of amyloid beta-protein and amyloid deposits in Alzheimer disease Cold Spring Harb. Perspect. Med. 2 2012 a006262
109. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. Mcdonald, and K. Beyreuther Amyloid plaque core protein in Alzheimer-disease and Down syndrome Proc. Natl. Acad. Sci. USA 82 1985 4245 4249
110. M.P. Mattson Pathways towards and away from Alzheimer's disease Nature 430 2004 631 639
111. K.G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J.C. Morris, K.E. Yarasheski, and R.J. Bateman Decreased clearance of CNS β-amyloid in Alzheimer's disease Science 330 2010 1774
112. J.M. Mc Donald, G.M. Savva, C. Brayne, A.T. Welzel, G. Forster, G.M. Shankar, D.J. Selkoe, P.G. Ince, D.M. Walsh, and M.R.C.C. Function The presence of sodium dodecyl sulphate-stable A beta dimers is strongly associated with Alzheimer-type dementia Brain 133 2010 1328 1341
113. C.A. McLean, R.A. Cherny, F.W. Fraser, S.J. Fuller, M.J. Smith, K. Beyreuther, A.I. Bush, and C.L. Masters Soluble pool of A beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 46 1999 860 866
114. 2+ ions J. Biol. Chem. 282 2007 16068 16078
115. M. Meyer-Luehmann, T.L. Spires-Jones, C. Prada, M. Garcia-Alloza, A. de Calignon, A. Rozkalne, J. Koenigsknecht-Talboo, D.M. Holtzman, B.J. Bacskai, and B.T. Hyman Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease Nature 451 2008 U720 U725
116. M. Meyer-Luehmann, M. Stalder, M.C. Herzig, S.A. Kaeser, E. Kohler, M. Pfeifer, S. Boncristiano, P.M. Mathews, M. Mercken, D. Abramowski, M. Staufenbiel, and M. Jucker Extracellular amyloid formation and associated pathology in neural grafts Nat. Neurosci. 6 2003 370 377
117. Y. Miller, B. Ma, and R. Nussinov Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states Proc. Natl. Acad. Sci. USA 107 2010 9490 9495
118. V. Minicozzi, F. Stellato, M. Comai, M.D. Serra, C. Potrich, W. Meyer-Klaucke, and S. Morante Identifying the minimal copper- and zinc-binding site sequence in amyloid-beta peptides J. Biol. Chem. 283 2008 10784 10792
119. T. Miura, K. Suzuki, N. Kohata, and H. Takeuchi Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes Biochemistry 39 2000 7024 7031
120. C. Morgan, M. Colombres, M.T. Nunez, and N.C. Inestrosa Structure and function of amyloid in Alzheimer's disease Prog. Neurobiol. 74 2004 323 349
121. U.C. Muller, C.U. Pietrzik, and T. Deller The physiological functions of the beta-amyloid precursor protein APP Exp. Brain Res. 217 2012 325 329
122. R. Nelson, M.R. Sawaya, M. Balbirnie, A.O. Madsen, C. Riekel, R. Grothe, and D. Eisenberg Structure of the cross-beta spine of amyloid-like fibrils Nature 435 2005 773 778
123. N. Nicolakakis, T. Aboulkassim, B. Ongali, C. Lecrux, P. Fernandes, P. Rosa-Neto, X.K. Tong, and E. Hamel Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist J. Neurosci. 28 2008 9287 9296
124. C. Opazo, X. Huang, R.A. Cherny, R.D. Moir, A.E. Roher, A.R. White, R. Cappai, C.L. Masters, R.E. Tanzi, N.C. Inestrosa, and A.I. Bush Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2) J. Biol. Chem. 277 2002 40302 40308
125. A.T. Petkova, R.D. Leapman, Z.H. Guo, W.M. Yau, M.P. Mattson, and R. Tycko Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils Science 307 2005 262 265
126. P. Picone, R. Carrotta, G. Montana, M.R. Nobile, P.L. San Biagio, and M. Di Carlo Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures Biophys. J. 96 2009 4200 4211
127. C.J. Pike, M.J. Overman, and C.W. Cotman Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro J. Biol. Chem. 270 1995 23895 23898
128. K.E. Pike, G. Savage, V.L. Villemagne, S. Ng, S.A. Moss, P. Maruff, C.A. Mathis, W.E. Klunk, C.L. Masters, and C.C. Rowe Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Brain 130 2007 2837 2844
129. S.W. Pimplikar Reassessing the amyloid cascade hypothesis of Alzheimer's disease Int. J. Biochem. Cell Biol. 41 2009 1261 1268
130. J. Poirier, J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, and S. Gauthier Apolipoprotein E polymorphism and Alzheimer's disease Lancet 342 1993 697 699
131. E. Portelius, N. Bogdanovic, M.K. Gustavsson, I. Volkmann, G. Brinkmalm, H. Zetterberg, B. Winblad, and K. Blennow Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease Acta Neuropathol. 120 2010 185 193
132. V.P. Prasher, M.J. Farrer, A.M. Kessling, E.M. Fisher, R.J. West, P.C. Barber, and A.C. Butler Molecular mapping of Alzheimer-type dementia in Down's syndrome Ann. Neurol. 43 1998 380 383
133. W. Qiang, W.M. Yau, Y.Q. Luo, M.P. Mattson, and R. Tycko Antiparallel beta-sheet architecture in Iowa-mutant beta-amyloid fibrils Proc. Natl. Acad. Sci. USA 109 2012 4443 4448
134. E.L. Que, D.W. Domaille, and C.J. Chang Metals in neurobiology: probing their chemistry and biology with molecular imaging Chem. Rev. 108 2008 1517 1549
135. T.D. Rae, P.J. Schmidt, R.A. Pufahl, V.C. Culotta, and T.V. O'Halloran Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase Science 284 1999 805 808
136. B. Raman, T. Ban, K. Yamaguchi, M. Sakai, T. Kawai, H. Naiki, and Y. Goto Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid beta peptide J. Biol. Chem. 280 2005 16157 16162
137. V.P. Reddy, X. Zhu, G. Perry, and M.A. Smith Oxidative stress in diabetes and Alzheimer's disease J. Alzheimers Dis. 16 2009 763 774
138. C. Reitz, C. Brayne, and R. Mayeux Epidemiology of Alzheimer disease Nat. Rev. Neurol. 7 2011 137 152
139. R. Resende, E. Ferreiro, C. Pereira, and C. Resende de Oliveira Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death Neuroscience 155 2008 725 737
140. F. Ricchelli, D. Drago, B. Filippi, G. Tognon, and P. Zatta Aluminum-triggered structural modifications and aggregation of beta-amyloids Cell. Mol. Life Sci. 62 2005 1724 1733
141. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, L. MacGregor, L. Kiers, R. Cherny, Q.X. Li, A. Tammer, D. Carrington, C. Mavros, I. Volitakis, M. Xilinas, D. Ames, S. Davis, K. Beyreuther, R.E. Tanzi, and C.L. Masters Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch. Neurol. 60 2003 1685 1691
142. B.R. Roberts, T.M. Ryan, A.I. Bush, C.L. Masters, and J.A. Duce The role of metallobiology and amyloid-ss peptides in Alzheimer's disease J. Neurochem. 120 2012 149 166
143. J.T. Rogers, A.I. Bush, H.H. Cho, D.H. Smith, A.M. Thomson, A.L. Friedlich, D.K. Lahiri, P.J. Leedman, X.D. Huang, and C.M. Cahill Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease Biochem. Soc. Trans. 36 2008 1282 1287
144. A.E. Roher, J.D. Lowenson, S. Clarke, A.S. Woods, R.J. Cotter, E. Gowing, and M.J. Ball Beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits-implications for the pathology of Alzheimer-disease Proc. Natl. Acad. Sci. USA 90 1993 10836 10840
145. M. Rozga, M. Kloniecki, M. Dadlez, and W. Bal A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1-40 peptide Chem. Res. Toxicol. 23 2010 336 340
146. M. Rozga, A.M. Protas, A. Jablonowska, M. Dadlez, and W. Bal The Cu(II) complex of A beta 40 peptide in ammonium acetate solutions. Evidence for ternary species formation Chem. Commun. 2009 1374 1376
147. A. Santner, and V.N. Uversky Metalloproteomics and metal toxicology of alpha-synuclein Metallomics 2 2010 378 392
148. R.X. Santos, S.C. Correia, X.L. Wang, G. Perry, M.A. Smith, P.I. Moreira, and X.W. Zhu Alzheimer's disease: diverse aspects of mitochondrial malfunctioning Int. J. Clin. Exp. Pathol. 3 2010 570 581
149. C.J. Sarell, C.D. Syme, S.E. Rigby, and J.H. Viles Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form Biochemistry 48 2009 4388 4402
150. 2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-beta from Alzheimer disease J. Biol. Chem. 285 2010 41533 41540
151. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S. Younkin Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease Nat. Med. 2 1996 864 870
152. M.L. Schlief, T. West, A.M. Craig, D.M. Holtzman, and J.D. Gitlin Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity Proc. Natl. Acad. Sci. USA 103 2006 14919 14924
153. L.E. Scott, and C. Orvig Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease Chem. Rev. 109 2009 4885 4910
154. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
155. P. Seubert, C. Vigopelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, C. Swindlehurst, R. Mccormack, R. Wolfert, D. Selkoe, I. Lieberburg, and D. Schenk Isolation and quantification of soluble Alzheimers beta-peptide from biological-fluids Nature 359 1992 325 327
156. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
157. M. Shibata, S. Yamada, S.R. Kumar, M. Calero, J. Bading, B. Frangione, D.M. Holtzman, C.A. Miller, D.K. Strickland, J. Ghiso, and B.V. Zlokovic Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J. Clin. Invest. 106 2000 1489 1499
158. M. Shoji, T.E. Golde, J. Ghiso, T.T. Cheung, S. Estus, L.M. Shaffer, X.D. Cai, D.M. Mckay, R. Tintner, B. Frangione, and S.G. Younkin Production of the Alzheimer amyloid-beta protein by normal proteolytic processing Science 258 1992 126 129
159. M. Siotto, S. Bucossi, and R. Squitti Copper status abnormalities and how to measure them in neurodegenerative disorders Recent Pat. CNS Drug Discov. 5 2010 182 194
160. M. Sjogren, H. Vanderstichele, H. Agren, O. Zachrisson, M. Edsbagge, C. Wikkelso, I. Skoog, A. Wallin, L.O. Wahlund, J. Marcusson, K. Nagga, N. Andreasen, P. Davidsson, E. Vanmechelen, and K. Blennow Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values Clin. Chem. 47 2001 1776 1781
161. L. Slomianka, G. Danscher, and C.J. Frederickson Labeling of the neurons of origin of zinc-containing pathways by intraperitoneal injections of sodium selenite Neuroscience 38 1990 843 854
162. D.G. Smith, R. Cappai, and K.J. Barnham The redox chemistry of the Alzheimer's disease amyloid beta peptide Biochim. Biophys. Acta-Biomembr. 1768 2007 1976 1990
163. M.A. Smith, P.L. Harris, L.M. Sayre, and G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. USA 94 1997 9866 9868
164. M. Sokolowska, and W. Bal Cu(II) complexation by "non- coordinating" N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES buffer) J. Inorg. Biochem. 99 2005 1653 1660
165. D.L. Sparks, and B.G. Schreurs Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 100 2003 11065 11069
166. R. Squitti, G. Barbati, L. Rossi, M. Ventriglia, G. Dal Forno, S. Cesaretti, F. Moffa, I. Caridi, E. Cassetta, P. Pasqualetti, L. Calabrese, D. Lupoi, and P.M. Rossini Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF beta-amyloid, and h-tau Neurology 67 2006 76 82
167. M. Stoltenberg, A.I. Bush, G. Bach, K. Smidt, A. Larsen, J. Rungby, S. Lund, P. Doering, and G. Danscher Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency Neuroscience 150 2007 357 369
168. N. Suzuki, T.T. Cheung, X.D. Cai, A. Odaka, L. Otvos, C. Eckman, T.E. Golde, and S.G. Younkin An increased percentage of long amyloid-beta protein secreted by familial amyloid-beta protein-precursor (beta-App(717)) mutants Science 264 1994 1336 1340
169. 2+ binding to amyloid-beta peptide (A beta) of Alzheimer's disease Biochim. Biophys. Acta Proteins Proteomics 1764 2006 246 256
170. C. Talmard, A. Bouzan, and P. Faller Zinc binding to amyloid-beta: isothermal titration calorimetry and Zn competition experiments with Zn sensors Biochemistry 46 2007 13658 13666
171. C. Talmard, R. Leuma Yona, and P. Faller Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28) J. Biol. Inorg. Chem. 14 2009 449 455
172. H. Tamano, and A. Takeda Dynamic action of neurometals at the synapse Metallomics 3 2011 656 661
173. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
174. N. Tolboom, W.M. van der Flier, M. Yaqub, T. Koene, R. Boellaard, A.D. Windhorst, P. Scheltens, A.A. Lammertsma, and B.N.M. van Berckel Differential association of C-11 PIB and F-18 FDDNP binding with cognitive impairment Neurology 73 2009 2079 2085
175. J.L. Tomic, A. Pensalfini, E. Head, and C.G. Glabe Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction Neurobiol. Dis. 35 2009 352 358
176. M. Torok, S. Milton, R. Kayed, P. Wu, T. McIntire, C.G. Glabe, and R. Langen Structural and dynamic features of Alzheimer's A beta peptide in amyloid fibrils studied by site-directed spin labeling J. Biol. Chem. 277 2002 40810 40815
177. V. Tougu, A. Karafin, and P. Palumaa Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide J. Neurochem. 104 2008 1249 1259
178. V. Tougu, A. Karafin, K. Zovo, R.S. Chung, C. Howells, A.K. West, and P. Palumaa Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators J. Neurochem. 110 2009 1784 1795
179. V. Tougu, A. Tiiman, and P. Palumaa Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity Metallomics 3 2011 250 261
180. S. Treusch, D.M. Cyr, and S. Lindquist Amyloid deposits protection against toxic protein species? Cell Cycle 8 2009 1668 1674
181. 2+ binding site of amyloid-beta Biophys. J. 99 2010 L84 L86
182. R. Tycko Progress towards a molecular-level structural understanding of amyloid fibrils Curr. Opin. Struct. Biol. 14 2004 96 103
183. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
184. D.M. Walsh, and D.J. Selkoe A beta oligomers-a decade of discovery J. Neurochem. 101 2007 1172 1184
185. S. Vasto, G. Candore, F. Listi, C.R. Balistreri, G. Colonna-Romano, M. Malavolta, D. Lio, D. Nuzzo, E. Mocchegiani, D. Di Bona, and C. Caruso Inflammation, genes and zinc in Alzheimer's disease Brain Res. Rev. 58 2008 96 105
186. H. Welander, J. Franberg, C. Graff, E. Sundstrom, B. Winblad, and L.O. Tjernberg A beta 43 is more frequent than A beta 40 in amyloid plaque cores from Alzheimer disease brains J. Neurochem. 110 2009 697 706
187. A.R. White, T. Du, K.M. Laughton, I. Volitakis, R.A. Sharples, M.E. Xilinas, D.E. Hoke, R.M. Holsinger, G. Evin, R.A. Cherny, A.F. Hill, K.J. Barnham, Q.X. Li, A.I. Bush, and C.L. Masters Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity J. Biol. Chem. 281 2006 17670 17680
188. C. Vigopelfrey, D. Lee, P. Keim, I. Lieberburg, and D.B. Schenk Characterization of beta-amyloid peptide from human cerebrospinal-fluid J. Neurochem. 61 1993 1965 1968
189. T. Wisniewski, J. Ghiso, and B. Frangione Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation Biochem. Biophys. Res. Commun. 179 1991 1247 1254
190. Z.G. Xiao, and A.G. Wedd The challenges of determining metal-protein affinities Nat. Prod. Rep. 27 2010 768 789
191. P. Zatta, D. Drago, S. Bolognin, and S.L. Sensi Alzheimer's disease, metal ions and metal homeostatic therapy Trends Pharmacol. Sci. 30 2009 346 355
192. I. Zawisza, M. Rózga, and W. Bal Affinity of copper and zinc ions to proteins and peptides related to neurodegenerative conditions (Aā, APP, α-synuclein, PrP) Coord. Chem. Rev. 256 2012 2297 2307
193. S. Zirah, S.A. Kozin, A.K. Mazur, A. Blond, M. Cheminant, I. Segalas-Milazzo, P. Debey, and S. Rebuffat Structural changes of region 1-16 of the Alzheimer disease amyloid beta-peptide upon zinc binding and in vitro aging J. Biol. Chem. 281 2006 2151 2161
194. K. Zou, J.S. Gong, K. Yanagisawa, and M. Michikawa A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage J. Neurosci. 22 2002 4833 4841